You are here:
StockWatch
#

StockWatch

Get Alerts

Articles

View all

Tata Motors down 4% after MD Karl Slym falls to death

Jan 27, 2014

Tata Motors down 4% after MD Karl Slym falls to death

Tata Motors fell almost 4 percent in the morning trade today following the news of its managing director Karl Slym's death. #Sensex #Tata Motors #BSE #StockWatch #Karl Slym
All Ranbaxy drugs made in India banned from US, stock crashes 20%

Jan 24, 2014

All Ranbaxy drugs made in India banned from US, stock crashes 20%

Staff at the Toansa facility were found to have retested raw materials and other ingredients after the items failed analytical testing "in order to produce acceptable findings," and did not report or investigate the failures, the FDA said. #StockWatch #Ranbaxy #Toansa
Investors need not worry about TCS stock, co still outperforms IT peers

Jan 17, 2014

Investors need not worry about TCS stock, co still outperforms IT peers

The investor darling today recorded its worst percentage loss since October 17. However, the stock had rallied almost 10 percent in the run-up to its results so far in the year 2014. #Infosys #TCS #EarningsShow #StockWatch #IT #N Chandrasekharan
HCL Tech hits record high on stellar Q3 earnings

Jan 16, 2014

HCL Tech hits record high on stellar Q3 earnings

Shares in HCL Technologies rose as much as 3.5 percent to a record high of Rs 1,377 after the company reported December-quarter consolidated net profit rose more than expected. #EarningsShow #StockWatch #IT #HCL Tech
Ranbaxy shares dip further on US FDA concerns

Jan 14, 2014

Ranbaxy shares dip further on US FDA concerns

Despite making a positive opening, shares of Ranbaxy Lab failed to sustain the momentum and fell by 2.13 per cent to Rs 429 on the BSE. On the NSE, the stock lost 2.31 percent to Rs 428.65. #StockWatch #Pharma #Ranbaxy Labs #USFDA
LIVE